1,121
Views
0
CrossRef citations to date
0
Altmetric
Hepatitis – Research Article

A retrospective study of hepatitis B vaccination in preterm birth and low birth weight infants born to hepatitis B surface antigen-positive mothers: Time to close the policy-practice gap

ORCID Icon, , , , , & show all
Article: 2155390 | Received 23 Sep 2022, Accepted 02 Dec 2022, Published online: 14 Dec 2022

References

  • Chawanpaiboon S, Vogel JP, Moller AB, Lumbiganon P, Petzold M, Hogan D, Landoulsi S, Jampathong N, Kongwattanakul K, Laopaiboon M, et al. Global, regional, and national estimates of levels of preterm birth in 2014: a systematic review and modelling analysis. Lancet Glob Health. 2019;7(1):e37–5. doi:10.1016/S2214-109X(18)30451-0.
  • Soans S, Mihalyi A, Berlaimont V, Kolhapure S, Dash R, Agrawal A. Vaccination in preterm and low birth weight infants in India. Hum Vaccin Immunother. 2022;18(1):1–12. doi:10.1080/21645515.2020.1866950.
  • Fan W, Zhang M, Zhu YM, Zheng YJ. Immunogenicity of hepatitis B vaccine in preterm or low birth weight infants: a meta-analysis. Am J Prev Med. 2020;59(2):278–87. doi:10.1016/j.amepre.2020.03.009.
  • Fortmann MI, Dirks J, Goedicke-Fritz S, Liese J, Zemlin M, Morbach H, Härtel C. Immunization of preterm infants: current evidence and future strategies to individualized approaches. Semin Immunopathol. 2022;44(6):767–84. doi:10.1007/s00281-022-00957-1.
  • Ost K, Oster NV, Jacobson EN, deHart MP, Englund JA, Hofstetter AM. Hepatitis B Vaccination of low birth weight infants in Washington state. Am J Perinatol. 2022;39(9):980–86. doi:10.1055/s-0040-1721372.
  • Gagneur A, Pinquier D, Quach C. Immunization of preterm infants. Hum Vaccin Immunother. 2015;11(11):2556–63. doi:10.1080/21645515.2015.1074358.
  • Kulkarni-Munje A, Malshe N, Palkar S, Amlekar A, Lalwani S, Mishra AC, Arankalle V. Immune response of Indian preterm infants to pentavalent vaccine varies with component antigens and gestational age. Front Immunol. 2021;12:592731. doi:10.3389/fimmu.2021.592731.
  • Freitas da Motta MS, Mussi-Pinhata MM, Jorge SM, Tachibana Yoshida CF, Sandoval de Souza CB. Immunogenicity of hepatitis B vaccine in preterm and full term infants vaccinated within the first week of life. Vaccine. 2002;20(11–12):1557–62. doi:10.1016/s0264-410x(01)00493-5.
  • Blondheim O, Bader D, Abend M, Peniakov M, Reich D, Potesman I, Handsher R, Gidoni I, Linder N. Immunogenicity of hepatitis B vaccine in preterm infants. Arch Dis Child Fetal Neonatal Ed. 1998;79(3):F206–08. doi:10.1136/fn.79.3.f206.
  • Lau YL, Tam AY, Ng KW, Tsoi NS, Lam B, Lam P, Yeung CY. Response of preterm infants to hepatitis B vaccine. J Pediatr. 1992;121(6):962–65. doi:10.1016/s0022-3476(05)80352-x.
  • World Health Organization. Hepatitis B vaccines: WHO position paper – July 2017. Wkly Epidemiol Rec. 2017;92(27):369–92.
  • Chaudhari T. Vaccinations in the newborn. Best Pract Res Clin Obstet Gynaecol. 2021;76:66–82. doi:10.1016/j.bpobgyn.2020.09.004.
  • Schillie S, Vellozzi C, Reingold A, Harris A, Haber P, Ward JW, Nelson NP. Prevention of hepatitis B virus infection in the United States: recommendations of the advisory committee on immunization practices. MMWR Recomm Rep. 2018;67(1):1–31. doi:10.15585/mmwr.rr6701a1.
  • Deng K, Liang J, Mu Y, Liu Z, Wang Y, Li M, Li X, Dai L, Li Q, Chen P, et al. Preterm births in China between 2012 and 2018: an observational study of more than 9 million women. Lancet Glob Health. 2021;9(9):e1226–41. doi:10.1016/S2214-109X(21)00298-9.
  • Qureshi A, Ijaz S, Syed A, Qureshi A, Khan AA. Periodontal infection: a potential risk factor for pre-term delivery of low birth weight (PLBW) babies. J Pak Med Assoc. 2005;55:448–52.
  • Liu J, Wang X, Wang Q, Qiao Y, Jin X, Li Z, Du M, Yan W, Jing W, Liu M, et al. Hepatitis B virus infection among 90 million pregnant women in 2853 Chinese counties, 2015-2020: a national observational study. Lancet Reg Health West Pac. 2021;16:100267. doi:10.1016/j.lanwpc.2021.100267.
  • Qin W, Meng X, Zhang L, Wang Y, Xu X, Li K, Xie S. The impact of long-term moderate level of vaccination coverage for epidemiology of varicella in Lu’an, China: should we change immunisation strategy now. Epidemiol Infect. 2020;148:e74. doi:10.1017/S0950268820000667.
  • Chen C, Zhang JW, Xia HW, Zhang HX, Betran AP, Zhang L, Hua XL, Feng LP, Chen D, Sun K, et al. Preterm birth in China between 2015 and 2016. Am J Public Health. 2019;109(11):1597–604. doi:10.2105/AJPH.2019.305287.
  • Hofstetter AM, Jacobson EN, deHart MP, Englund JA. Early childhood vaccination status of preterm infants. Pediatrics. 2019;144(3). doi:10.1542/peds.2018-3520.
  • Chen L, Feng P, Shaver L, Wang Z. Maternal mortality ratio in China from 1990 to 2019: trends, causes and correlations. BMC Public Health. 2021;21(1):1536. doi:10.1186/s12889-021-11557-3.
  • Polaris Observatory Collaborators. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study. Lancet Gastroenterol Hepatol. 2018;3(6):383–403. doi:10.1016/S2468-1253(18)30056-6.
  • Cui F, Woodring J, Chan P, Xu F. Considerations of antiviral treatment to interrupt mother-to-child transmission of hepatitis B virus in China. Int J Epidemiol. 2018;47(5):1529–37. doi:10.1093/ije/dyy077.
  • Liu J, Liang W, Jing W, Liu M. Countdown to 2030: eliminating hepatitis B disease, China. Bull World Health Organ. 2019;97(3):230–38. doi:10.2471/BLT.18.219469.
  • GBD 2019 Hepatitis B Collaborators. Global, regional, and national burden of hepatitis B, 1990–2019: a systematic analysis for the global burden of disease study 2019. Lancet Gastroenterol Hepatol. 2022;7(9):796–829. doi:10.1016/S2468-1253(22)00124-8.
  • Indolfi G, Easterbrook P, Dusheiko G, Siberry G, Chang MH, Thorne C, Bulterys M, Chan PL, El-Sayed MH, Giaquinto C, et al. Hepatitis B virus infection in children and adolescents. Lancet Gastroenterol Hepatol. 2019;4(6):466–76. doi:10.1016/S2468-1253(19)30042-1.
  • Bary-Weisberg D, Stein-Zamir C. Vaccination timeliness and completeness among preterm and low birthweight infants: a national cohort study. Hum Vaccin Immunother. 2021;17(6):1666–74. doi:10.1080/21645515.2020.1840255.
  • Li F, Wang Q, Zhang L, Su H, Zhang J, Wang T, Huang D, Wu J, Yan Y, Fan D. The risk factors of transmission after the implementation of the routine immunization among children exposed to HBV infected mothers in a developing area in northwest China. Vaccine. 2012;30(49):7118–22. doi:10.1016/j.vaccine.2012.09.031.